GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Inventories, Finished Goods

GSK (GSK) Inventories, Finished Goods : $2,054 Mil (As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is GSK Inventories, Finished Goods?

GSK's quarterly finished goods stayed the same from Jun. 2024 ($0 Mil) to Sep. 2024 ($0 Mil) but then increased from Sep. 2024 ($0 Mil) to Dec. 2024 ($2,054 Mil).

GSK's annual finished goods increased from Dec. 2022 ($1,564 Mil) to Dec. 2023 ($1,842 Mil) and increased from Dec. 2023 ($1,842 Mil) to Dec. 2024 ($2,054 Mil).


GSK Inventories, Finished Goods Historical Data

The historical data trend for GSK's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Inventories, Finished Goods Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,267.47 2,821.81 1,563.95 1,841.77 2,054.36

GSK Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,841.77 - - - 2,054.36

GSK Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


GSK Business Description

Industry
Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.